Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.02.12.637946

Genome Mining of Streptomyces sp. PB17 from Cuatro Cienegas Basin Reveals Biosynthetic Potential for Novel Neurotherapeutics.

Abstract

The Cuatro Cienegas Basin (CCB), a biodiversity hotspot in Coahuila, Mexico, harbors microbial communities adapted to extreme oligotrophic conditions, making it a promising site for novel bioactive compound discovery.. This study reports the isolation, whole-genome sequencing, and analysis of Streptomyces sp. PB17, a thermotolerant actinomycete retrieved from the karstic Poza La Becerra. Phylogenomic analyses including TYGS and VBCG pipelines, combined with ANI values, support its classification as a putatively novel species. Streptomyces PB17s genome mining revealed 31 biosynthetic gene clusters (BGCs), with over 10 exhibiting low similarity to known pathways, highlighting its potential for novel bioactive compounds. Among these, ribosomally synthesized and post-translationally modified peptides (RiPPs) demonstrated strong predictive scores for blood-brain barrier penetration properties, representing promising candidates for neurotherapeutic applications. These findings underscore the biotechnological potential of actinomycetes retrieved from extreme sites and emphasize the importance of underexplored ecosystems like the CCB in natural product discovery, including neurotherapeutic research.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Martinez-Olivas, M. A., Melchor-Rangel, S. A., Mendoza-Cibrian, M. A., Benavides-Garcia, P., De la Torre-Zavala, S.. 2025-02-18. Genome Mining of Streptomyces sp. PB17 from Cuatro Cienegas Basin Reveals Biosynthetic Potential for Novel Neurotherapeutics.. https://doi.org/10.1101/2025.02.12.637946

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Structural variation in repeat elements is widespread in normal human tissues and in tumorigenesis

Somatic mosaicism contributes to genomic variation, yet postzygotic structural variants remain under-characterized. We performed long- and short-read WGS from multiple individuals (n=47 normal tissues; n=168 samples) and identified mosaic structural variants in all individuals and germ layers, impacting a median 285.2 kb/genome. Nearly half of breakpoints were independently validated, with tissue distributions reflecting both early and late developmental origins. Most mosaic variants were repeat-mediated and 8.3% overlapped functional elements, an enrichment compared to germline variants. To extend these analyses in samples where long-read sequencing is infeasible, we measured repeat alterations from short-read sequencing, recapitulating mosaic tissue-specific differences. We characterized tumor- and tissue- specific variation in repeats across 15 cancer types and found tumor-related repeat variation to be similar in scale to that of normal mosaic variation. Tracking repeat changes in cell-free DNA provided a noninvasive approach for tumor monitoring. Our analyses revealed widespread repeat-driven structural variation in health and disease.

genomics↗

RNA isoform-resolved multiplexed sequencing with bioorthogonal barcoding

RNA isoform dysregulation drives disease pathogenesis and is the target of FDA-approved splice-switching therapeutics. However, multiplexed sequencing methods discard splice junction information because only 3' termini are barcoded and counted. Here, we repurpose acylation and click chemistries to conjugate bioorthogonal barcodes (bobcodes) directly onto multiple internal positions along cellular RNAs. Bobcoded RNAs from multiple samples are pooled for multiplexed cDNA synthesis, during which reverse transcriptase switches from each RNA template onto its tethered bobcode with greater than 99% accuracy in species mixing experiments. Bobcode attachment intervals set cDNA insert sizes without a library fragmentation step, and priming with poly(dT) or random hexamers selects between 3'-end counting and full-length isoform capture. A bioorthogonal barcode-sequencing (BOB-seq v0.1) drug screen identifies transcriptome-wide on- and off-target RNA splicing effects and outperforms existing multiplexing RNA sequencing methods in workflow simplicity, sample-to-sample variability, and barcoding accuracy. Bobcodes add isoform resolution to scalable multiplexed RNA sequencing.

genomics↗

Structural polymorphism and population-variable coding capacity of HERV-K(HML-2) in human pangenomes

Approximately 8% of the human genome is derived from ancient retroviral infections. The most recently integrated of these endogenous retroviruses is the HERV-K(HML-2) clade, whose expression has been associated with cancer, amyotrophic lateral sclerosis, and embryogenesis. Studies of HERV expression, particularly HML-2, have relied predominantly on short-read sequencing. However, the high similarity among HML-2 proviruses prevents many short reads from being assigned uniquely to individual loci. We therefore compared haplotype-resolved long-read genome assemblies from 292 donors to resolve variation in proviral structure and coding capacity. Several loci previously thought to be fixed were structurally polymorphic. Tandem arrays occurred at 13 loci and contained up to six proviral copies in a single array. At 8q11.23, we identified a previously undescribed full-length provirus in one haplotype. All 583 other haplotypes carried a solo-LTR. We found that standard reference genomes failed to represent the coding capacity retained in many individuals, whose proviruses contained intact open reading frames despite disruptive mutations in the reference sequences. Short-read genotypes left 32.5% of the tested donor-variant pairs unresolved at sites associated with viral reading frames. These findings show why HML-2 expression must be interpreted in the context of the structural and coding alleles each individual carries.

genomics↗